We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

U.S., EUROPE, AND CHINA MYELODYSPLASTIC SYNDROME (MDS) TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2020 - 2027)

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, by Drugs (Lenalidomide, Decitabine, Azacitidine, Luspatercept, and Phase 3 Drugs), by Route of Administration (Injection and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country/Region (U.S., Europe, and China) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In: 09 Jul, 2021
Code: CMI4513
Page number: 255
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drugs
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
  - Market Opportunity Map
U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Market Trends
- Product Launch
- PEST Analysis
- Key Developments
- Collaborations & Acquisitions
- Epidemiology
- Brand Analysis
U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Supply Chain Analysis
- Government Initiatives
U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By Drugs, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Introduction
  - Market Share Analysis, 2020 and 2027(%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Lenalidomide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Decitabine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Azacitidine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Luspatercept
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Phase 3 Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By Route of Administration, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Introduction
  - Market Share Analysis, 2020 and 2027(%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Injection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million
U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By Distribution Channel, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Introduction
  - Market Share Analysis, 2020 and 2027(%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Country at Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (Value in US$ Mn) and (Volume in Units)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (Value in US$ Mn) and (Volume in Units)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (Value in US$ Mn) and (Volume in Units)
U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By

Country/Region, 2016 – 2027(Value in US$ Mn) and (Volume in Units)
- Introduction
  - Market Share Analysis, 2020 and 2027(%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Country/Regional Trends
- U.S.
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - U.K.
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - Germany
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - Italy
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - France
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - Spain
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - Russia
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
    - Rest of Europe
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
- China
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (Value in US$ Mn) and (Volume in Units)
Company Profiles
- Bristol Myers Squibb
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Otsuka Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Reddy's Laboratories Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharmaceutical Industries Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cipla Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Acceleron Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Onconova Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aprea Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Geron
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fibrogen, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Jazz Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lixte Biotechnology Holdings, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Gilead Sciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- CrystalGenomics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ALX Oncology Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Keros Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Section
- Research Methodology
- About us

*Browse 77 market data tables and 41 figures on "myelodysplastic syndrome (MDS) treatment market” - U.S., Europe, and China forecast to 2027

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

U.S., EUROPE, AND CHINA MYELODYSPLASTIC SYNDROME (MDS) TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2020 - 2027)

Table of Contents (Version-2026)

Research Objectives and Assumptions

Market Purview

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market Dynamics

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By Drugs, 2016 – 2027(Value in US$ Mn) and (Volume in Units)

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By Route of Administration, 2016 – 2027(Value in US$ Mn) and (Volume in Units)

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By Distribution Channel, 2016 – 2027(Value in US$ Mn) and (Volume in Units)

U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market, By

Country/Region, 2016 – 2027(Value in US$ Mn) and (Volume in Units)

Company Profiles

Section

EXISTING CLIENTELE

U.S. Office:

Menu

Reader Club

Help

Connect With Us :

Secure Payment By :